Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa

Published:2015-10-16 Issue:1 Volume:38 Page:70-79
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Cotrina-Luque Jesús,Gil-Navarro Maria Victoria,Acosta-García Héctor,Alfaro-Lara Eva Rocío,Luque-Márquez Rafael,Beltrán-García Margarita,Bautista-Paloma Francisco Javier

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

http://link.springer.com/content/pdf/10.1007/s11096-015-0208-y.pdf

Reference18 articles.

1. Jhee SS, Kern JW, Burm JP, Yellin AE, Gill MA. Piperacillin–tazobactam pharmacokinetics in patients with intraabdominal infections. Pharmacotherapy. 1995;15:472–8.

2. Auclair B, Ducharme MP. Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses. Antimicrob Agents Chemother. 1999;43:1465–8.

3. Facca BF, Trisenberg SN, Barr LL. Population pharmacokinetics of continuous infusion piperacillin–tazobactam. J Infect Dis Pharmacother. 2002;5:51–67.

4. Tazocel (Piperacillin–tazobactam) product insert. http://www.aemps.gob.es/cima/pdfs/es/ft/59660/FT_59660.pdf . Accessed 13 Jan 2015.

5. Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis. 2013;56:272–82.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams;International Journal of Antimicrobial Agents;2024-10

2. Meta-analysis on safety of standard vs prolonged infusion of beta-lactams;2024-04-09

3. Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis;Expert Review of Anti-infective Therapy;2024-03-05

4. Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta-analysis of randomized controlled trials;Journal of Infection and Chemotherapy;2023-09

5. International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-08